Vasomotor and vascular effects of hormone replacement therapy
- PMID: 12106634
- DOI: 10.1016/s0002-9149(01)02218-4
Vasomotor and vascular effects of hormone replacement therapy
Abstract
Cardiovascular risk factors impair endothelium-dependent vasodilation as well as other functions of the endothelium, thereby predisposing the patient to atherosclerosis and its overt clinical manifestations. Loss of endogenous estrogen also leads to reduced bioavailability of endothelium-derived nitric oxide. In premenopausal women, the impairment of endothelial function develops within 1 month of surgical ovariectomy and is reversed by the administration of exogenous 17 beta-estradiol. Exogenous estrogen administration restores endothelial function by enhancing nitric oxide synthesis through genomic and nongenomic mechanisms and by reducing oxidative stress and nitric oxide breakdown. The effect of progesterone on endothelial function is still under investigation. In animal studies, medroxyprogesterone acetate (MPA) counteracts estrogen's beneficial effects on endothelial function and on coronary plaque size. In humans, however, the addition of progesterone to estradiol does not appreciably attenuate estrogen-associated endothelium-dependent vasodilation. Secondary prevention trials with conjugated equine estrogen plus MPA have no proven benefit in reducing coronary events, progression of angiographic coronary atherosclerosis, or incidence of cerebrovascular events. This suggests that beneficial effects of estrogen on endothelial function are counterbalanced by detrimental effects, perhaps because of proinflammatory and prothrombotic actions. The selective estrogen receptor modulators are currently under investigation as agents that might retain the favorable, without possessing the unfavorable, effects of estrogen on the vascular system.
Similar articles
-
Comparative vascular effects of hormone replacement therapy and raloxifene in women at increased cardiovascular risk.Gynecol Endocrinol. 2004 Jun;18(6):291-8. doi: 10.1080/09513590410001729888. Gynecol Endocrinol. 2004. PMID: 15497491 Clinical Trial.
-
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women.Arterioscler Thromb Vasc Biol. 2001 Sep;21(9):1512-9. doi: 10.1161/hq0901.095565. Arterioscler Thromb Vasc Biol. 2001. PMID: 11557681 Clinical Trial.
-
Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen.Circulation. 2001 Oct 9;104(15):1773-8. doi: 10.1161/hc4001.097035. Circulation. 2001. PMID: 11591613 Clinical Trial.
-
Comparative cardiovascular effects of different progestins in menopause.Int J Fertil Womens Med. 2001 Sep-Oct;46(5):248-56. Int J Fertil Womens Med. 2001. PMID: 11720197 Review.
-
Estrogens and Coronary Artery Disease: New Clinical Perspectives.Adv Pharmacol. 2016;77:307-60. doi: 10.1016/bs.apha.2016.05.003. Epub 2016 Jun 29. Adv Pharmacol. 2016. PMID: 27451102 Review.
Cited by
-
A cross-sectional and 10-year prospective study of postmenopausal estrogen therapy and blood pressure, renal function, and albuminuria: the Rancho Bernardo Study.Menopause. 2011 Jun;18(6):629-37. doi: 10.1097/gme.0b013e3181fca9c4. Menopause. 2011. PMID: 21326121 Free PMC article.
-
Ethinyl estradiol-to-desogestrel ratio impacts endothelial function in young women.Contraception. 2009 Jan;79(1):41-9. doi: 10.1016/j.contraception.2008.07.025. Epub 2008 Oct 28. Contraception. 2009. PMID: 19041440 Free PMC article.
-
Rapid estrogen receptor signaling mediates estrogen-induced inhibition of vascular smooth muscle cell proliferation.Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1837-43. doi: 10.1161/ATVBAHA.112.300752. Epub 2013 Jun 6. Arterioscler Thromb Vasc Biol. 2013. PMID: 23744991 Free PMC article.
-
Chronic black tea extract consumption improves endothelial function in ovariectomized rats.Eur J Nutr. 2016 Aug;55(5):1963-72. doi: 10.1007/s00394-015-1012-0. Epub 2015 Aug 15. Eur J Nutr. 2016. PMID: 26276555 Free PMC article.
-
Bioidentical hormones for women with vasomotor symptoms.Cochrane Database Syst Rev. 2016 Aug 1;2016(8):CD010407. doi: 10.1002/14651858.CD010407.pub2. Cochrane Database Syst Rev. 2016. PMID: 27479272 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources